Quiet on the insider front: nobody at Design Therapeutics, Inc. bought or sold DSGN shares on the open market this past year.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters. On the institutional side, 137 funds reported holding DSGN at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | William Arsani | Director | Sell | 217,627 | $5.25 | $1.1M | SEC |
| Aug 14, 2025 | William Arsani | Director | Sell | 345,000 | $5.25 | $1.8M | SEC |
| Dec 19, 2024 | Prasad Deepa | Director | Sell | 3,806 | $6.27 | $24K | SEC |
| Aug 12, 2024 | William Arsani | Director | Sell | 814,874 | $4.25 | $3.5M | SEC |
| Mar 25, 2024 | Schmid John P. | Director | Buy | 17,809 | $3.74 | $67K | SEC |
| Mar 25, 2024 | Schmid John P. | Director | Buy | 9,156 | $3.62 | $33K | SEC |
| Mar 25, 2024 | Berger Heather A. | Director | Buy | 1,300 | $3.74 | $5K | SEC |
| Oct 2, 2023 | LAPPE RODNEY W | Director | Buy | 21,000 | $2.35 | $49K | SEC |
| Aug 30, 2023 | Prasad Deepa | Director | Buy | 12,000 | $2.31 | $28K | SEC |
| Aug 30, 2023 | William Arsani | Director | Buy | 275,000 | $2.15 | $591K | SEC |
| Aug 30, 2023 | William Arsani | Director | Buy | 1,960,000 | $2.44 | $4.8M | SEC |
There were no open-market insider trades in DSGN in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
137 investment managers reported holding DSGN in SEC Form 13F filings for Q2 2026.
No congressional trades in DSGN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).